Stock listing

Aquis:PHME Pharma Mar SA Share Price

UK listing (Aquis) of Pharma Mar SA · home listing BME:PHM

Follow Pharma Mar SA into a list and get an email when it puts out news.

Home listing price · BME:PHM

€70.80 EUR +1.55 (+2.2%)

Close on Oct 21, 2026 · This listing has no price on 6ix; the price shown is the home listing's, BME:PHM

Past 3 months -13.6% · daily closes, Jul 6, 2026 – Oct 21, 2026, adjusted for splits
Day range
€69.00 – €70.90 EUROct 21, 2026
Volume
28,048 sharesOct 21, 2026
Market cap
€1.22B EURAt the close on Oct 21, 2026 · price × 17.26M shares outstanding
Pharma Mar SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
BME:PHM · Home€70.80 EUR+1.55 (+2.2%)28,048€69.50€70.90€69.00€69.25Close on Oct 21, 2026
OTC:PHMMF$94.60 USD0.00 (0.0%)—$94.60$94.60$94.60$94.60Close on Oct 21, 2026
Frankfurt:PMRA€67.70 EUR-0.85 (-1.2%)—€67.70€67.70€67.70€68.55Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 21, 2026 – Oct 21, 2026 · BME:PHM · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€70.80+1.55+2.2%€69.50€70.90€69.0028,048
€69.25+0.80+1.2%€67.95€70.05€67.7023,081
€68.45+0.55+0.8%€67.50€68.45€67.2026,204
€67.90-0.50-0.7%€68.40€69.60€67.9028,402
€68.40+1.10+1.6%€67.45€68.85€66.7033,621
€67.30+0.85+1.3%€66.80€67.90€66.3533,156
€66.45-1.80-2.6%€68.00€69.20€66.4534,695
€68.25-1.20-1.7%€69.75€70.15€68.2516,715
€69.45+0.85+1.2%€68.60€69.85€68.3523,960
€68.60-1.15-1.6%€69.55€69.55€68.0532,846
€69.75-0.55-0.8%€69.70€70.75€69.7014,861
€70.30+0.65+0.9%€70.45€71.50€69.6521,642
€69.65-1.75-2.5%€71.30€71.55€69.5030,249
€71.40+0.65+0.9%€70.50€71.65€69.6027,211
€70.75-2.35-3.2%€72.45€73.05€70.7547,245
€73.10+0.70+1.0%€72.90€73.30€72.1023,783
€72.40-1.50-2.0%€74.00€74.10€72.3519,746
€73.90-0.05-0.1%€74.05€74.50€73.1515,001
€73.95+0.45+0.6%€73.50€74.90€73.5021,369
€73.50+0.65+0.9%€72.85€74.30€72.2023,497
€72.85-1.80-2.4%€75.30€75.50€72.8523,312
€74.65+0.70+0.9%€74.20€75.05€74.0026,275
€73.95+0.30+0.4%€73.75€74.40€72.8020,985
€73.65-1.35-1.8%€75.95€75.95€73.0544,400
€75.00-1.25-1.6%€76.25€76.70€75.0054,453
€76.25+0.10+0.1%€77.00€77.00€75.9512,847
€76.15-0.30-0.4%€76.00€76.95€75.7515,642
€76.45-0.05-0.1%€75.50€76.80€75.5029,506
€76.50-0.45-0.6%€77.25€77.25€75.8523,995
€76.95-1.70-2.2%€78.65€79.05€76.1042,350
€78.65-1.35-1.7%€80.00€80.00€77.8057,503
€80.00-2.20-2.7%€82.30€82.85€76.9095,703
€82.20-1.25-1.5%€84.00€84.00€82.2011,728
€83.45-0.30-0.4%€83.70€84.00€82.6018,110
€83.75+1.00+1.2%€83.00€84.50€82.8520,611
€82.75+0.05+0.1%€82.20€84.10€82.1526,527
€82.70+1.35+1.7%€81.65€83.50€80.8524,428
€81.35-1.45-1.8%€82.70€82.80€81.3045,068
€82.80-0.80-1.0%€83.65€84.30€82.8016,313
€83.600.000.0%€84.30€84.90€83.6018,853
€83.60-0.25-0.3%€83.50€85.10€83.5029,225
€83.85+1.55+1.9%€82.80€84.40€82.5029,695
€82.30-1.00-1.2%€82.95€83.00€80.9026,264
€83.30+1.15+1.4%€82.20€83.35€80.8045,400
€82.15+0.05+0.1%€82.65€84.40€81.5040,746
€82.10+0.25+0.3%€82.15€82.45€80.5030,061
€81.85-2.55-3.0%€83.80€84.00€81.7026,728
€84.40+0.45+0.5%€84.20€84.85€83.1035,055
€83.95-0.55-0.7%€84.90€85.40€83.5559,945
€84.50+2.45+3.0%€82.00€84.95€82.0071,228
€82.05+0.20+0.2%€82.50€82.90€81.3036,016
€81.85+0.95+1.2%€80.90€82.95€80.7547,147
€80.90+2.50+3.2%€79.15€81.25€78.6554,384
€78.40+0.70+0.9%€78.05€79.35€77.9019,977
€77.70+0.65+0.8%€76.75€79.05€74.8548,582
€77.05-1.75-2.2%€79.50€79.55€76.9540,448
€78.80+0.45+0.6%€78.85€80.15€78.7528,620
€78.35-0.70-0.9%€79.40€79.90€77.7533,078
€79.05-1.10-1.4%€80.80€80.80€78.2041,918
€80.15-0.85-1.0%€79.95€80.70€77.2559,467
€81.00+2.50+3.2%€78.95€81.60€78.3542,245
€78.50-1.50-1.9%€79.95€80.00€78.0541,057
€80.00+0.70+0.9%€79.70€80.70€78.9030,743
€79.30+0.40+0.5%€79.00€79.95€78.7022,309
€78.90+0.10+0.1%€78.60€79.70€78.4032,306
€78.80+2.55+3.3%€76.40€79.45€75.7055,459
€76.25+0.45+0.6%€76.45€76.90€74.8543,059
Ticker
Aquis:PHME
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Aquis
Currency
EUR

What changed lately

Calls

Replays

  • Pharma Mar (Madrid:PHM) Q3 2023 Earnings Call

    Fri, Oct 27, 2023

    Watch Transcript

  • Pharma Mar (Madrid:PHM) Q4 2022 Earnings Call

    Mon, May 01, 2023

    Watch Transcript

Latest news

Pharma Mar: Consolidated Financial Statements and Consolidated Directors' Report (Consolidated Financial Statements and Consolidated Directors)

Mar 13, 2026

Press Release (PR PhM Results FY2025 final 1)

Feb 27, 2026

PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer

Jun 3, 2025

Annual Report (ANNUAL REPORT 2024)

Apr 24, 2025

Separate Financial Statements (SEPARATE FINANCIAL STATEMENTS 2024)

Apr 24, 2025

Annual Report (ANNUAL REPORT PHARMAMAR 1)

Mar 18, 2025

PharmaMar estará presente en la 17ª edición de la European Large &MidCap event que se celebra en Paris

Oct 3, 2017

All Pharma Mar SA news

Decks

Pharma Mar SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 7 in all · newest Mar 13, 2026 · oldest 2017
Calls
2 calls with a replay · 2 with a transcript · latest Oct 27, 2023
Decks
13 decks · latest September 2026

Where Pharma Mar SA is listed

ListingExchangeCountryCurrency
BME:PHM · Home listingMadridSpainEUR
gettex:PMRAgettexGermanyEUR
VIE:PHMViennaAustriaEUR
OTC:PHMMFOTCUnited StatesUSD
LS Exchange:A2P9YTLS ExchangeGermanyEUR
Tradegate:PMRATradegateGermanyEUR
LSIN:0RC6LSINUnited KingdomEUR
Lang & Schwarz:A2P9YTLang & SchwarzGermanyEUR
Aquis:PHMEAquisUnited KingdomEUR
Dusseldorf:PMRADusseldorfGermanyEUR
Stuttgart:PMRAStuttgartGermanyEUR
Aquis:PHME · This pageAquisUnited KingdomEUR
Turquoise:PHMETurquoiseUnited KingdomEUR
Frankfurt:PMRAFrankfurtGermanyEUR
Hamburg:PMRAHamburgGermanyEUR
Munich:PMRAMunichGermanyEUR

Log in to ask 6ix AI your own questions about Pharma Mar SA.